Jordan Park Group’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
EP
Jordan Park Group's ARKG Position: Q3 2021 in Review
Jordan Park Group sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 21,823 shares — an estimated $2.02M sold.
Jordan Park Group first reported a position in ARKG in Q1 2021 and held it in 2 quarters. The position peaked at $2.02M in Q2 2021. 470 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.
- Jordan Park Group reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
- Jordan Park Group sold 21,823 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $2.02M.
- Jordan Park Group first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 2 quarters.
- Jordan Park Group's ARK Genomic Revolution ETF position peaked at $2.02M in Q2 2021.
- 470 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.
Based on Jordan Park Group's 13F filing for Q3 2021, filed 19 Oct 2021.